Annie Neild
General Counsel at FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Profile
Annie Neild is currently the Executive VP & Head-Global Regulatory Affairs at NewAmsterdam Pharma Co. NV.
Previously, she worked as the Head-Regulatory Affairs at Corvidia Therapeutics, Inc. in 2020.
Ms. Neild holds a doctorate degree from Yale University.
Annie Neild active positions
| Companies | Position | Start |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | General Counsel | 2021-02-28 |
Former positions of Annie Neild
| Companies | Position | End |
|---|---|---|
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | General Counsel | 2020-06-30 |
Training of Annie Neild
| Yale University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Annie Neild
